Forward Regulatory Plan 2021-2023: Proposed New Regulations under the Controlled Drugs and Substances Act with respect to Supervised Consumption Sites and Services

Title of Regulatory Initiative

Proposed New Regulations under the Controlled Drugs and Substances Act with respect to Supervised Consumption Sites and Services

Enabling Act

Controlled Drugs and Substances Act


Health Canada is proposing to develop new regulations under the Controlled Drugs and Substances Act (CDSA) that would seek to:

Regulatory cooperation efforts (domestic and international)

Not applicable

Potential impacts on Canadians, including businesses

Problematic substance use has devastating impacts across Canada, on individuals, families and communities. Evidence shows that when properly established and operated, SCS save lives and can provide people who use drugs with access to important health and social services, including substance use treatment for those who are ready.

It is anticipated that these potential new regulations would reduce the overall regulatory burden on SCS applicants and operators, while continuing to respect the public safety objectives of the CDSA.

Stakeholders that may be impacted by the change include: supervised consumption site and overdose prevention site applicants and operators, people with lived and living experience, health professionals, provinces and territories, and communities, law enforcement, and provinces, territories, and municipalities.


Canadians were invited to provide comments on a Notice of Intent, which was published in the Canada Gazette, Part I, on August 15, 2020, for a 60-day public comment period that ended on October 14, 2020. All feedback received through this consultation will inform the development of the potential new regulations.

Canadians will have the opportunity to provide comments on the regulatory proposal during the Canada Gazette, Part I public comment period, which is expected to take place in fall 2021.

Further information

Additional information can be requested from the departmental contact.

Departmental contact information

Jennifer Pelley
Acting Director
Office of Legislative and Regulatory Affairs
Controlled Substances Directorate
Controlled Substances and Cannabis Branch
Health Canada

Telephone: 613-410-1829

Date the regulatory initiative was first included in the Forward Regulatory

February 2021

Consult Health Canada's acts and regulations web page for:

Consult the following for links to the Cabinet Directive on Regulation and supporting policies and guidance, and for information on government-wide regulatory initiatives implemented by departments and agencies across the Government of Canada:

To learn about upcoming or ongoing consultations on proposed federal regulations, visit:

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: